Stockscreener 앱 받기
74.56
1.21%
-0.5851
Bridgebio Pharma Inc 주식(BBIO)의 최신 뉴스
Castleark Management LLC Cuts Position in BridgeBio Pharma, Inc. $BBIO - MarketBeat
Gilder Gagnon Howe & Co. LLC Boosts Stake in BridgeBio Pharma, Inc. $BBIO - MarketBeat
Eventide Asset Management LLC Decreases Stake in BridgeBio Pharma, Inc. $BBIO - MarketBeat
BridgeBio Oncology Therapeutics: Promising KRAS Drug DeveloperIn My View, At Least - Seeking Alpha
BridgeBio Pharma stock hits all-time high at 75.13 USD - Investing.com
BridgeBio Pharma stock hits all-time high at 75.13 USD By Investing.com - Investing.com Australia
BridgeBio Pharma (BBIO) Valuation After Attruby-Driven Earnings Beat and Renewed Analyst Support - Yahoo Finance
What Recent Clinical Wins Mean For BridgeBio Pharma’s Evolving Growth Story - Yahoo Finance
Frontier Capital Management Co. LLC Sells 233,538 Shares of BridgeBio Pharma, Inc. $BBIO - MarketBeat
Bernstein initiates BridgeBio Pharma stock coverage with Outperform rating By Investing.com - Investing.com Canada
Bernstein Initiates BridgeBio Pharma at Outperform With $94 Price Target - marketscreener.com
This Option Care Health Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Thursday - Benzinga
HighVista Strategies LLC Increases Stock Position in BridgeBio Pharma, Inc. $BBIO - MarketBeat
Bernstein Initiates Coverage of BridgeBio Pharma (BBIO) with Outperform Recommendation - Nasdaq
BBIO Gets "Outperform" Rating as Bernstein Initiates Coverage | - GuruFocus
Federated Hermes Inc. Takes Position in BridgeBio Pharma, Inc. $BBIO - MarketBeat
BridgeBio (BBIO) Unveils Promising Preclinical Data for Cancer T - GuruFocus
BridgeBio (BBIO) Unveils Promising Preclinical Data for Cancer Treatment - GuruFocus
Apuli Maricel, chief accounting officer, sells $148k in BridgeBio (BBIO) - Investing.com Canada
This Hot Biotech Stock Just Set New All-Time Highs - Barchart.com
BridgeBio Pharma (NASDAQ:BBIO) CAO Sells $148,520.00 in Stock - MarketBeat
Insider Sell Alert: Maricel Apuli Sells 2,000 Shares of BridgeBi - GuruFocus
Stempoint Capital LP Reduces Stock Holdings in BridgeBio Pharma, Inc. $BBIO - MarketBeat
Invesco Ltd. Has $120.95 Million Stock Position in BridgeBio Pharma, Inc. $BBIO - MarketBeat
89,312 Shares in BridgeBio Pharma, Inc. $BBIO Acquired by WINTON GROUP Ltd - MarketBeat
Insider Selling: BridgeBio Pharma (NASDAQ:BBIO) CEO Sells 40,000 Shares of Stock - MarketBeat
BridgeBio Pharma CEO Kumar sells $5.9 million in BBIO stock By Investing.com - Investing.com Canada
Bridgebio Pharma Insider Sold Shares Worth $5,908,476, According to a Recent SEC Filing - marketscreener.com
BridgeBio Pharma (NASDAQ:BBIO) Hits New 12-Month HighTime to Buy? - MarketBeat
Price-Driven Insight from (BBIO) for Rule-Based Strategy - news.stocktradersdaily.com
BridgeBio Pharma, Inc. $BBIO Holdings Lifted by Bosun Asset Management LLC - MarketBeat
Tema Etfs LLC Sells 25,530 Shares of BridgeBio Pharma, Inc. $BBIO - MarketBeat
Edgestream Partners L.P. Makes New $1.92 Million Investment in BridgeBio Pharma, Inc. $BBIO - MarketBeat
BridgeBio Pharma, Inc. $BBIO Position Cut by Affinity Asset Advisors LLC - MarketBeat
10 Health Care Stocks With Whale Alerts In Today's Session - Benzinga
Norges Bank Purchases New Holdings in BridgeBio Pharma, Inc. $BBIO - MarketBeat
Lymphatic Malformations Market Expected to Experience Major - openPR.com
Legal & General Group Plc Purchases 23,716 Shares of BridgeBio Pharma, Inc. $BBIO - MarketBeat
Panagora Asset Management Inc. Boosts Stake in BridgeBio Pharma, Inc. $BBIO - MarketBeat
72,047 Shares in BridgeBio Pharma, Inc. $BBIO Acquired by Capital Fund Management S.A. - MarketBeat
Rhumbline Advisers Grows Stock Holdings in BridgeBio Pharma, Inc. $BBIO - MarketBeat
How BridgeBio Pharma Inc. stock valuations compare to rivalsMarket Activity Recap & Free Fast Gain Swing Trade Alerts - Newser
BridgeBio Pharma stock hits 52-week high at $72.36 By Investing.com - Investing.com South Africa
BridgeBio Pharma (NASDAQ:BBIO) Reaches New 52-Week HighWhat's Next? - MarketBeat
BridgeBio Pharma stock hits 52-week high at $72.36 - Investing.com
What valuation multiples suggest for BridgeBio Pharma Inc. stockJuly 2025 EndofMonth & Accurate Entry and Exit Point Alerts - Newser
Prudential Financial Inc. Has $5.07 Million Stock Holdings in BridgeBio Pharma, Inc. $BBIO - MarketBeat
What dividend safety score for BridgeBio Pharma Inc. stockJuly 2025 Reactions & High Yield Stock Recommendations - Newser
BridgeBio Pharma Surges 170% as New Clinical Partnerships Spark Valuation Debate - Yahoo Finance
Is BridgeBio Pharma Inc. (2CL) stock cheap by valuation metricsJuly 2025 Snapshot & Consistent Income Trade Recommendations - Newser
Can BridgeBio Pharma Inc. (2CL) stock ride next bull market cycleJuly 2025 PreEarnings & Accurate Intraday Trade Tips - Newser
Should You Grab This ‘Strong Buy’ Growth Stock With 56% Upside? - Yahoo Finance
Swiss National Bank Has $10.99 Million Stock Position in BridgeBio Pharma, Inc. $BBIO - MarketBeat
F m Investments LLC Decreases Stake in BridgeBio Pharma, Inc. $BBIO - MarketBeat
American Century Companies Inc. Buys 62,646 Shares of BridgeBio Pharma, Inc. $BBIO - MarketBeat
Why BridgeBio Pharma Inc. stock could rally in 2025Quarterly Performance Summary & AI Powered Market Entry Strategies - BỘ NỘI VỤ
BridgeBio Pharma, Inc. $BBIO Shares Purchased by Cetera Investment Advisers - MarketBeat
Breakout Move: Will BridgeBio Pharma Inc. stock maintain growth storyMarket Performance Recap & Daily Price Action Insights - BỘ NỘI VỤ
BridgeBio (BBIO) Q3 2025 Earnings Call Transcript - The Globe and Mail
1.08%
1.31%
자본화:
|
볼륨(24시간):